BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 35710501)

  • 1. Contrast-Enhanced Ultrasound Features of Histopathologically Proven Hepatocellular Carcinoma in the Non-cirrhotic Liver: A Multicenter Study.
    Dong Y; Wang WP; Lee WJ; Meloni MF; Clevert DA; Chammas MC; Tannapfel A; Forgione A; Piscaglia F; Dietrich CF
    Ultrasound Med Biol; 2022 Sep; 48(9):1797-1805. PubMed ID: 35710501
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Applications of Dynamic Contrast-Enhanced Ultrasound in Differential Diagnosis of Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma in Non-cirrhotic Liver.
    Dong Y; Chen S; Möller K; Qiu YJ; Lu XY; Zhang Q; Dietrich CF; Wang WP
    Ultrasound Med Biol; 2023 Aug; 49(8):1780-1788. PubMed ID: 37156676
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of Hepatocellular Carcinoma Tumor Size on Sonazoid Contrast-Enhanced Ultrasound Enhancement Features.
    Chen S; Qiu YJ; Zhang Q; Lu XY; Huang YL; Dong Y; Wang WP
    Ultrasound Med Biol; 2024 Jan; 50(1):39-46. PubMed ID: 37778901
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Real-life assessment of standardized contrast-enhanced ultrasound (CEUS) and CEUS algorithms (CEUS LI-RADS®/ESCULAP) in hepatic nodules in cirrhotic patients-a prospective multicenter study.
    Strobel D; Jung EM; Ziesch M; Praktiknjo M; Link A; Dietrich CF; Klinger C; Schultheiß M; Jesper D; Schellhaas B
    Eur Radiol; 2021 Oct; 31(10):7614-7625. PubMed ID: 33855588
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Imaging Features of Hepatocellular Carcinoma in the Non-Cirrhotic Liver with Sonazoid-Enhanced Contrast-Enhanced Ultrasound.
    Chen S; Qiu YJ; Zuo D; Shi SN; Wang WP; Dong Y
    Diagnostics (Basel); 2022 Sep; 12(10):. PubMed ID: 36291962
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Imaging Features of Fibrolamellar Hepatocellular Carcinoma with Contrast-Enhanced Ultrasound.
    Dong Y; Wang WP; Mao F; Zhang Q; Yang D; Tannapfel A; Meloni MF; Neye H; Clevert DA; Dietrich CF
    Ultraschall Med; 2021 Jun; 42(3):306-313. PubMed ID: 32102105
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differentiation of regenerative nodule, dysplastic nodule, and small hepatocellular carcinoma in cirrhotic patients: a contrast-enhanced ultrasound-based multivariable model analysis.
    Duan Y; Xie X; Li Q; Mercaldo N; Samir AE; Kuang M; Lin M
    Eur Radiol; 2020 Sep; 30(9):4741-4751. PubMed ID: 32307563
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contrast-enhanced ultrasound of hepatocarcinogenesis in liver cirrhosis.
    Wu W; Chen MH; Sun M; Yan K; Yang W; Li JY
    Chin Med J (Engl); 2012 Sep; 125(17):3104-9. PubMed ID: 22932189
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CEUS in hepatocellular carcinoma and intrahepatic cholangiocellular carcinoma in 320 patients - early or late washout matters: a subanalysis of the DEGUM multicenter trial.
    Wildner D; Bernatik T; Greis C; Seitz K; Neurath MF; Strobel D
    Ultraschall Med; 2015 Apr; 36(2):132-9. PubMed ID: 25812115
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LI-RADS-CEUS - Proposal for a Contrast-Enhanced Ultrasound Algorithm for the Diagnosis of Hepatocellular Carcinoma in High-Risk Populations.
    Schellhaas B; Wildner D; Pfeifer L; Goertz RS; Hagel A; Neurath MF; Strobel D
    Ultraschall Med; 2016 Dec; 37(6):627-634. PubMed ID: 27486793
    [No Abstract]   [Full Text] [Related]  

  • 11. Contrast ultrasound LI-RADS LR-5 identifies hepatocellular carcinoma in cirrhosis in a multicenter restropective study of 1,006 nodules.
    Terzi E; Iavarone M; Pompili M; Veronese L; Cabibbo G; Fraquelli M; Riccardi L; De Bonis L; Sangiovanni A; Leoni S; Zocco MA; Rossi S; Alessi N; Wilson SR; Piscaglia F;
    J Hepatol; 2018 Mar; 68(3):485-492. PubMed ID: 29133247
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contrast-Enhanced Ultrasound Patterns for the Non-invasive Diagnosis of Hepatocellular Carcinoma: A Prospective Multicenter Study in Histologically Proven Liver Lesions in a Real-Life Setting Demonstrating the Benefit of Extended Late Phase Observation.
    Schellhaas B; Bernatik T; Dirks K; Jesper D; Mauch M; Potthoff A; Zimmermann P; Strobel D
    Ultrasound Med Biol; 2021 Nov; 47(11):3170-3180. PubMed ID: 34417066
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characteristics of contrast-enhanced ultrasound in distinguishing small (≤3 cm) hepatocellular carcinoma from intrahepatic cholangiocarcinoma.
    Shin SK; Choi DJ; Kim JH; Kim YS; Kwon OS
    Medicine (Baltimore); 2018 Oct; 97(41):e12781. PubMed ID: 30313099
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radiomics machine-learning signature for diagnosis of hepatocellular carcinoma in cirrhotic patients with indeterminate liver nodules.
    Mokrane FZ; Lu L; Vavasseur A; Otal P; Peron JM; Luk L; Yang H; Ammari S; Saenger Y; Rousseau H; Zhao B; Schwartz LH; Dercle L
    Eur Radiol; 2020 Jan; 30(1):558-570. PubMed ID: 31444598
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential application of dynamic contrast enhanced ultrasound in predicting microvascular invasion of hepatocellular carcinoma.
    Dong Y; Qiu Y; Yang D; Yu L; Zuo D; Zhang Q; Tian X; Wang WP; Jung EM
    Clin Hemorheol Microcirc; 2021; 77(4):461-469. PubMed ID: 33459703
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interobserver Agreement for Contrast-Enhanced Ultrasound (CEUS)-Based Standardized Algorithms for the Diagnosis of Hepatocellular Carcinoma in High-Risk Patients.
    Schellhaas B; Pfeifer L; Kielisch C; Goertz RS; Neurath MF; Strobel D
    Ultraschall Med; 2018 Dec; 39(6):667-674. PubMed ID: 29879746
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contrast-enhanced ultrasound features of histologically proven small (≤20 mm) liver metastases.
    Dong Y; Zhang XL; Mao F; Huang BJ; Si Q; Wang WP
    Scand J Gastroenterol; 2017 Jan; 52(1):23-28. PubMed ID: 27577113
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic Accuracy of CEUS LI-RADS for the Characterization of Liver Nodules 20 mm or Smaller in Patients at Risk for Hepatocellular Carcinoma.
    Huang JY; Li JW; Lu Q; Luo Y; Lin L; Shi YJ; Li T; Liu JB; Lyshchik A
    Radiology; 2020 Feb; 294(2):329-339. PubMed ID: 31793849
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HCCs lacking arterial phase hyperenhancement (APHE) on contrast-enhanced ultrasound (CEUS) - a diagnostic challenge. Findings from the prospective multicenter DEGUM CEUS HCC trial.
    Strobel D; Agaimy A; Jesper D; Zundler S; Schellhaas B
    Ultraschall Med; 2023 Dec; 44(6):606-613. PubMed ID: 36781161
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of Early Hepatocellular Carcinoma and High-Grade Dysplastic Nodules on Contrast-Enhanced Ultrasound: Correlation With Histopathologic Findings.
    Fan PL; Xia HS; Ding H; Dong Y; Chen LL; Wang WP
    J Ultrasound Med; 2020 Sep; 39(9):1799-1808. PubMed ID: 32378794
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.